Global Biodefense Market size forecast to exceed $17bn by 2024 - PowerPoint PPT Presentation

About This Presentation
Title:

Global Biodefense Market size forecast to exceed $17bn by 2024

Description:

Biodefense Market Size By Product, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024 – PowerPoint PPT presentation

Number of Views:24

less

Transcript and Presenter's Notes

Title: Global Biodefense Market size forecast to exceed $17bn by 2024


1
Global Biodefense Market size worth 17bn by
2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Biodefense Market
  • Global biodefense market size was driven by the
    anthrax segment, which was USD 3 billion in 2015
    and is anticipated to grow at 5 from 2016 to
    2024.
  • Revenue growth will be propelled by smallpox
    segment that is set to increase at 7.4 CAGR
    estimations to exceed USD 4 billion by 2024.
  • Eminent companies entered into contracts with the
    government for addressing a range of healthcare,
    scientific, national security and international
    security issues, which has led to high U.S.
    biodefense market share.  

3
Continued...
  • European countries of Germany and UK are set to
    witness lucrative growth rate due to designated
    funding policies in place.
  • Companies operating in the industry include Xoma
    Corporation, Emergent Biosolutions, Cleveland
    BioLabs, Nanotherapeutics, SIGA Technologies,
    etc. Presence of extensive product portfolio and
    strong pipeline will contribute to profitability.

4
U.S. Biodefense Market Size, by Product, 2012 -
2024 (USD Million)

5

Browse Full Market Research Report On
Biodefense Market _at_ http//goo.gl/StkvoL
Request for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/714 https//www.gminsights.com/request-sample/de
tail/49
6
360 Analysis
  • Product Analysis
  • Anthrax contributed 31.5 to the overall
    biodefense market share in 2015, with target size
    slated to exceed USD 4.2 billion by 2023.
     Bacillus anthracis is recognized to be of
    highest priority in biodefense research, and
    placed among the nine agents in class A as per
    the classification by CDC. This was followed by
    smallpox, which is now eradicated worldwide
    following the global immunization process.
  • Regional Analysis
  • North America contributed the largest regional
    share, with USD 8.9 billion in 2015. U.S.
    biodefense market share dominated North American
    revenue, which can be attributed to the
    increasing government initiatives, funding for
    biodefense, and implementation of Project
    BioShield in 2004 with an objective of research
    fund allocation across the federal agencies.
  • Competitive Market Share
  • The major players include Xoma Corporation,
    Emergent Biosolutions, PharmaAthene,
    Bavarian-Nordic, SIGA Technologies, and Cleveland
    BioLabs, etc.


7
Stay In Touch Website www.gminsights.com Soci
al Media
Write a Comment
User Comments (0)
About PowerShow.com